Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APEX1 | P27695 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | ANPEP | P15144 | 1/20 | 0.41 |
| ▸ | DPP4 | P27487 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.39 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.39 |
| ▸ | APP | P05067 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | S100B | P04271 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2759722 | 0.93 | APEX1 (0.48) | APEX1ALDH1A1TSHRANPEPDPP4 | |
| SCHEMBL26799323 | 0.85 | ANPEP (0.43) | ALDH1A1ANPEPDPP4APP | |
| SCHEMBL15826863 | 0.83 | APEX1 (0.44) | APEX1ALDH1A1TSHRANPEPDPP4 | |
| SCHEMBL10053398 | 0.80 | ALDH1A1 (0.60) | APEX1ALDH1A1TSHRRXFP1ENPP2 | |
| SCHEMBL15448519 | 0.78 | APEX1 (0.40) | APEX1ALDH1A1TSHRANPEPDPP4 | |
| SCHEMBL7593002 | 0.77 | CA9 (0.65) | APEX1ALDH1A1TSHRNPSR1CA12 | |
| SCHEMBL14678932 | 0.77 | ALDH1A1 (0.46) | APEX1ALDH1A1TSHRANPEPDPP4 | |
| SCHEMBL14444651 | 0.76 | ALDH1A1 (0.37) | APEX1ALDH1A1TSHRANPEPDPP4 | |
| SCHEMBL12891172 | 0.76 | CA9 (0.63) | APEX1ALDH1A1TSHRNPSR1CA12 | |
| SCHEMBL13125182 | 0.75 | ANPEP (0.43) | APEX1ALDH1A1TSHRANPEPDPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11806661-B2 | Polymer and method for producing the same, gas separation membrane, gas separation module, and gas separation apparatus using the polymer, and m-phenylenediamine compound | FUJIFILM CORPORATION (JP) | 2023-11-07 | — | — | US | disclosed |
| US-11806661-B2 | Polymer and method for producing the same, gas separation membrane, gas separation module, and gas separation apparatus using the polymer, and m-phenylenediamine compound | FUJIFILM CORPORATION (JP) | 2023-11-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11806661-B2 | Polymer and method for producing the same, gas separation membrane, gas separation module, and gas separation apparatus using the polymer, and m-phenylenediamine compound | PRMT9, PRMT1, PNMT | APEX1 1430/4885ALDH1A1 2452/4885TSHR 1442/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.